AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Imunon, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S6FLZ2
1.24▼ 0.01 (-1.20%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.25
Day's Range
1.16 – 1.25
52-Week Range
0.96 – 5.03
Volume
22.5K
Avg Volume
107.4K
Share Statistics
Shares Outstanding
Employees
20
Exchange
XNAS
Listed
1995-07-24
Share count as of August 10, 2026

Imunon, Inc. Common Stock (IMNN) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Imunon, Inc. Common Stock (IMNN)
What is Imunon, Inc. Common Stock's Market Cap?
Imunon, Inc. Common Stock's Market Cap is $6.9M, based on as-reported figures from SEC (XBRL) filings.
What is Imunon, Inc. Common Stock's Net Income (TTM)?
Imunon, Inc. Common Stock's Net Income (TTM) is -$14.7M, based on as-reported figures from SEC (XBRL) filings.
What is Imunon, Inc. Common Stock's EBITDA?
Imunon, Inc. Common Stock's EBITDA is -$14.5M, based on as-reported figures from SEC (XBRL) filings.
What is Imunon, Inc. Common Stock's Diluted EPS (TTM)?
Imunon, Inc. Common Stock's Diluted EPS (TTM) is -2.62, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IMNNAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Total operating expenses
Loss from operations
Other income (expense):
Non-Operating Income (Expense)
Interest expense———
Total other income (expense), net—
Net loss
Deemed Dividend – Series A Preferred Stock———
Net loss available to common share available to common shareholders———
Earnings Per Share (Basic)
Earnings Per Share (Diluted)